🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open-label, Phase II interventional study in order to assess eff...
Status
Completed
Location
University of Colorado Hospital
Start Date
2020-11-23
Trial ID
NCT04508647
Treatments Being Tested
The primary objective of the study is to compare the prevalence rate of maj...
Status
Recruiting
Location
BRIUMVI® Pregnancy Registry Virtual Research Coordination Center
Start Date
2024-06-01
Trial ID
NCT06433765
Treatments Being Tested
Ublituximab (also known as LFB-R603) is a monoclonal antibody that specific...
Status
Completed
Location
Johns Hopkins University School of Medicine
Start Date
2016-01
Trial ID
NCT02276963
Treatments Being Tested
The purpose of this study is to determine whether ublituximab in combinatio...
Status
Terminated
Location
TG Therapeutics Investigational Trial Site
Start Date
2012-11-21
Trial ID
NCT01744912
Treatments Being Tested
The proposed study is a pilot study of ublituximab involving people with mu...
Status
Recruiting
Location
Johns Hopkins University
Start Date
2026-02-10
Trial ID
NCT07389590
Treatments Being Tested
This study determines the Annualized Relapse Rate (ARR) in participants wit...
Status
Completed
Location
TG Therapeutics RMS Investigational Trial site
Start Date
2017-08-25
Trial ID
NCT03277248
Treatments Being Tested
The main objective of this Phase 2 study is to assess the efficacy of ublit...
Status
Recruiting
Location
TG Therapeutics Investigational Trial Site
Start Date
2026-07-27
Trial ID
NCT07680946
Treatments Being Tested
The purpose of this study is to determine whether ublituximab is safe and e...
Status
Completed
Location
TG Therapeutics Investigational Trial Site
Start Date
2012-07-19
Trial ID
NCT01647971
Treatments Being Tested
The primary purpose of this study is to evaluate the efficacy of ublituxima...
Status
Recruiting
Location
TG Therapeutics Investigational Trial Site
Start Date
2026-07-30
Trial ID
NCT07673744
Treatments Being Tested
The purpose of this study is to evaluate safety, effiectiveness, and to gai...
Status
Recruiting
Location
TG Therapeutics Investigational Trial Site
Start Date
2024-07-22
Trial ID
NCT06433752
Treatments Being Tested